Loading
Archives of Dentistry
ISSN: 2689-6222
Volume 3, Issue 1, p1-31
Articles published in this issue are Open Access and licensed under Creative Commons Attribution License (CC BY NC) where the readers can reuse, download, distribute the article in whole or part by mentioning proper credits to the authors.
Impact of Age on Prognostic Treatment Outcomes Among Oral Squamous Cell Carcinoma Patients: Evidence from Sri Lanka
Introduction: Disease free survival is the optimum treatment outcome in cancer management. We explored the impact of age on key treatment outcomes among a group of Sri Lankan oral squamous cell carcinoma patients. Material & Methods: We studied clinical records of 44 oral squamous cell carcinoma patients consisted of age- matched two groups (22 in each group) who had close surgical margins and clear surgical margins respectively.
Arch Dent, 2021, Volume 3, Issue 1, p1-7 | DOI: 10.33696/dentistry.3.016Respiratory Protection - Even in the Bigger Picture, it is Often the Smallest Details that Take Your Breath Away
It is surprising and even endearing in a way that we, as humans, live life looking ahead with hope, always believing in a better tomorrow, sometimes being oblivious to risks and dangers, often telling ourselves that bad things probably only happen to others and that the threats mentioned are in reality not as bad as they seem. As health care workers, although fear is supposed to be one of the greatest motivators, we bring a bit of this nonchalant attitude to our workplaces in being slightly indifferent especially to the dangers we know but can’t see and thus do not fear, in what is often referred to as the ‘health belief’ model.
Arch Dent, 2021, Volume 3, Issue 1, p8-10 | DOI: 10.33696/dentistry.3.017The Role of Selected Habits, Periodontal Disease and Oral Hygiene Status on the Occurrence and Prognosis of Oral Mucosal Lesions
Background & Aim: Patients presenting with an array of benign oral mucosal diseases to oral & maxillofacial (OMF) units practicing risk habits such as betel chewing could be at high risk of poor oral health and progressing into Oral Potentially Malignant Disorders (OPMD) or oral cancer. Against this backdrop, we investigated the possible role of selected habits, periodontal disease an oral hygiene in occurrence and prognosis of oral mucosal lesions, among a cohort of patients in Sri Lanka.
Arch Dent, 2021, Volume 3, Issue 1, p11-18 | DOI: 10.33696/dentistry.3.018Scalable 3D Screen Printing Technology in Pharmaceutical Manufacturing - High Degree of Freedom in Terms of Drug Choice
Additive manufacturing has the potential to revolutionize the pharmaceutical industry, enabling the production of customized drugs for the mass market. However, concerns over scalability, low mechanical resistance, low printing resolution and limited material choices have so far hindered the practical application of current 3D printing (3DP) technologies. Although conceptually similar, each uses its own method to deposit and cure the material.
Arch Dent, 2021, Volume 3, Issue 1, p19-21 | DOI: 10.33696/dentistry.3.019Socio-demographic Determinants, Patterns, and Treatment Outcomes of Dental Trauma Patients Treated at a Restorative Dentistry Unit, National Dental Teaching Hospital (NDTH), Sri Lanka
Aim: This study aimed to determine the socio-demographic determinants, patterns, and treatment outcomes of dental trauma patients treated at a Restorative Dentistry Unit, National Dental Hospital (Teaching) (NDTH), Sri Lanka. Material and methods: This retrospective hospital-based study analyzed data of a total sample of 422 patients according to age, gender, cause, number, and the type of traumatized teeth from the clinical records of traumatized patients.
Arch Dent, 2021, Volume 3, Issue 1, p22-31 | DOI: 10.33696/dentistry.3.020COVID-19 Clinical Research
While the global COVID-19 pandemic has challenged the entire humanity and health systems, it also triggered researchers to urgently perform clinical trials to assess the safety and efficacy of many agents and modalities to combat COVID-19. As of April 22, over 650 clinical studies have been registered both in USA and internationally. Results from these studies are also coming at a brisk pace in this unprecedented emergency.
Therapeutic Values of Ketamine for COVID-19-Cared Patients: An Expert’s Point of View
Ketamine has long been used in the field of anesthesia [1]. Its rapid and long-acting analgesic effects associated with its dissociative properties have also established its use in prehospital and emergency department patients.
A Bioinformatics Protocol for Rational Design of Peptide Vaccines and the COVID-19 Rampage
The currently ongoing coronavirus pandemic, the SARSCOV- 2, interchangeably referred to as the COVID-19 infection, has in a short span of time altered the ways and means of almost all of mankind. So strong has been its effect that all human activity ceased in one way or another for a considerable time, led to significant loss of life and economic drain of.
Lessons Learnt from COVID-19: How Can We Prepare for Another Pandemic?
Five months into the COVID-19 pandemic, the U.S. death toll from the virus has now surpassed 100,000 people. Many more cases remain nationwide, while an unknown number of patients currently harbor the virus asymptomatically. While health officials are now optimistic regarding the decline in prevalence and number of deaths due to COVID-19 and the possibility of a vaccine by the fall, we cannot lose sight of the bigger picture: the next pandemic.
Safety of Using Rituximab Therapy During COVID-19 Pandemic
Our modern world is facing extraordinary circumstances while passing through a serious pandemic caused by the novel coronavirus (COVID-19) which may lead to multi-organ system failure & death. Bcell depletion could compromise antiviral immunity, which makes the safety of rituximab use in the COVID19 era unclear.
Educators as Essential Workers in the Era of COVID-19: Applying Lessons from Disaster Recovery
In the article, “Mental Health Framework: Coronavirus pandemic in post-Katrina New Orleans” [1], Shervington and Richardson offer recommendations about how to anticipate and address disaster-related, trauma exposures associated with the coronavirus pandemic
How Well Do Hemodialysis Patients Respond to the BNT162b2 mRNA COVID-19 Vaccine?
In January 2020, the World Health Organization (WHO) classified COVID-19 to be a Public Health Emergency of International Concern and declared it a pandemic on March 11, 2020 [1]. Over one hundred and eighty-five million people have been infected by SARS-CoV-2 and roughly four million have died worldwide so far
STARTTS Capoeira Angola Project Bantu: Combining Alternative Therapeutic Intervention with Sport for Traumatized Young Refugees: On the Way to Recovery
During the last decade, the world experienced an incredible increase in displaced populations; a staggering 70.8 million, which has been a direct outcome of war and human rights violations. This figure includes 25.9 million having been identified as refugees, and 51% constituting children below 18 years of age which has been documented as the highest figure in a decade.
Predicting COVID-19 Hospitalized Patients’ Outcome with Homocysteine
The COVID-19 pandemic has provoked a global, rapid increase of cases due to the high infectivity of the etiological agent, COVID-19 virus. In February 2021, over 110 million confirmed COVID-19 cases with 1 million deaths were reported worldwide (www.who.int).
Multidirectional Benefits of Nanotechnology in the Diagnosis, Treatment and Prevention of Tuberculosis
Despite the curious advancement in medical science and therapeutics, tuberculosis (TB) persist the primary factor of mortality than any other infectious disease and socioeconomic disaster for millions of people around the world. According to the World Health Organization (WHO), World’s One-third of the population is infected with this disease and of these, 8 to 10 million people develop active disease and 2 million people die each year and the rest of the infected people remain asymptomatic.
Dexamethasone: The First Drug to be Shown to Decrease Mortality in Critically Ill Patients with COVID-19
Background: The precise role of corticosteroids for treatment of coronavirus disease 2019 (COVID-19) is unclear due to lack of randomized trials. Objective: To review the therapeutic value of corticosteroids for treatment of hospitalized patients with COVID-19 with more emphasis on randomized trials. Methods: English literature search of electronic databases supplemented by manual search up to June 29, 2020. Search terms included corticosteroids, COVID-19, dexamethasone, methylprednisolone, hydrocortisone, mortality, safety. Randomized trials were the main focus of research, but observational studies were also reviewed.
How to Prevent Rehospitalization in Patients with COVID-19
Since December 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) caused by 2019 Novel Coronavirus (2019-nCoV) has resulted in 89,000 cases of Corona Virus Disease 2019 (COVID-19), formerly known as Novel Coronavirus Pneumonia (NCP) in China, including 2,450 deaths.
Long-Term Use of Oral Bisphosphonates and Fracture Risk in Men with Traumatic Spinal Cord Injury
Lower extremity fractures in individuals with a spinal cord injury (SCI) cause significant morbidity [1] and contribute to excess mortality [2]. Early identification of persons at highest risk for fracture is possible using bone mineral density (BMD) testing by dual-energy X-ray absorptiometry (DXA) imaging
Classical Drug and its New Role in COVID-19 Management
COVID-19 is the new emerging viral infection that already cause global public health problem. More than 220 countries/territories are already attacked and there are more than 17 million patients around the world. This disease was firstly reported in China then in Indochina and extended worldwide. The patient can have febrile respiratory illness and there are many asymptomatic and mild symptomatic cases. The new viral respiratory infection causes several medical and non-medical problems and it is a big challenge to be managed.
Drugs and Family Medicine: Form and Content
Choosing an individual medication for a particular patient is one of the most important clinical decisions in family medicine (FM). Prescription of drugs is currently the main tool of FM and that’s the main source of prescription of drugs. The drugs are used by general practitioners (GPs) to manage a wide range of health problems that are addressed at this level of medical care have tangible results. But should the drug be the GP’s main therapeutic resource? Drugs arrive to serve the purposes of the GP, but finally, the GP redefines its own goals according to the drugs.
Preparing for a More Public Health-Aware Practice of Medicine in Response to COVID-19
After one year in a pandemic, we mourn the loss of over half a million lives in the United States, and over four million worldwide, and remain concerned over the challenges facing the families of 35 million people in the United States, and 200 million worldwide, who have suffered from cases of COVID-19.
Quantifying Respiratory Airborne Particle Dispersion Control Through Improvised Reusable Masks: The Physics of Non-Pharmaceutical Interventions for Reducing SARS-CoV-2 (COVID-19) Airborne Transmission
In light of the current pandemic from rapid transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19) and significant morbidity, there has been inconsistent medical guidance given to the public regarding the wearing of non-medical improvised fabric masks or face coverings to reduce the transmission of COVID-19.
The Use of Hydroxychloroquine and Interferons for the Prophylaxis of COVID-19
At the beginning of Covid-19 pandemic, we proposed to use hydroxychloroquine (HCQ) and intranasal interferon (IFN) a-2b spray to prevent SARS-CoV-2. Since then, clinical trials testing these two drugs separately for the treatment and prophylaxis have been reported. A consensus is forming that HCQ and IFNs are not effective in treating severe Covid-19. However, the pathogenesis of Covid-19 suggests that early intervention could reduce the infection and prevent the progression from mild to severe Covid-19.
Rehabilitation Providers’ Experiences with Rapid Telerehabilitation Implementation During the COVID-19 Pandemic in the United States
Telehealth has been around since the 1960s as a healthcare delivery modality, though it did not gain widespread acceptance as a viable and reliable clinical tool until the late 1990s, when digital imaging and high speed, high bandwidth telecommunications technology became widely available [1]. Historical boundaries to its acceptance and
COVID-19 Disease and SARS-CoV-2 Vaccination in Patients with Cancer
Since the declaration of COVID-19 as a pandemic in March 2020, there have been more than 100 million reported cases of COVID-19 worldwide and more than 2.1 million deaths. The purpose of this editorial is to review recent updates regarding COVID-19 disease and SARS-CoV-2 vaccination in cancer patients.
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.